NEW YORK (GenomeWeb News) – Cancer Research UK said yesterday that it has launched a multicenter personalized medicine project with industrial partners Pfizer and AstraZeneca that will seek to demonstrate how genetic tests could be used to match cancer patients to the treatments that work best for them.